Login / Signup

Assessing the effectiveness of targeted agents in adjuvant therapy for patients with metastatic colorectal cancer undergoing surgical resection: a retrospective cohort study.

Yi-Chia SuChih-Chien WuYu-Hsun ChenChien-Chou SuYu-Ching ChangMeng-Che HsiehYea-Huei Kao Yang
Published in: Therapeutic advances in medical oncology (2024)
Adjuvant chemotherapy plus TAs may improve survival in patients with initially unresectable tumors who underwent conversion surgery following neoadjuvant therapy with TAs, especially in those who respond well to the targeted therapy. Our study underscores the importance of stratifying patients with mCRC based on tumor resectability when selecting the adjuvant therapy regimen.
Keyphrases